Gary Saphire, DPM
Primary Podiatric Medicine · Brooklyn, NYNPI 1376537134
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,121 of the $1,533 with a category attached, or 73.2%. 14 manufacturers reported payments, led by Acell, Inc. at 38.2% of the total. Reporting peaked in 2020 at $594 and has fallen 94.1% since, to $35 in 2025.
Across 24 payments — averaging $63.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acell, Inc.$585
- Celularity Inc.$165
- Stryker$157
- Smith+Nephew$150
- Integra Lifesciences Corporation$123
- Angiodynamics, Inc.$97
- plus $256 from 8 others
What the payments were for
- Travel & lodging$41127%
- Food & beverage$1,12173%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acell, Inc. | 4 | $585 |
| Celularity Inc. | 2 | $165 |
| Stryker | 2 | $157 |
| Smith+Nephew | 3 | $150 |
| Integra Lifesciences Corporation | 1 | $123 |
| Angiodynamics, Inc. | 1 | $97 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $93 |
| Vertex | 1 | $35 |
| Advanced Oxygen Therapy Inc. | 3 | $32 |
| Hartmann USA, Inc. | 2 | $29 |
| Melinta Therapeutics, LLC | 1 | $22 |
| AbbVie | 1 | $17 |
| Nabriva Therapeutics, PLC | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$369
- INTEGRA DERMAL REGENERATION TEMPLATE$123
- PRIMATRIX$123
- Santyl$119
- REGRANEX$119
- Oasis$119
- AUGMENT INJECTABLE$117
How this compares
$1,533 in reported general payments places this provider in the 75th percentile of 85 primary podiatric medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Econazole Nitrate | 49 | $1,663 |
| Ketoconazole | 44 | $1,649 |
| Clotrimazole | 50 | $1,424 |
| Ammonium Lactate | 25 | $831 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 35 | $705 |
| Diclofenac Sodium | 18 | $464 |
| Duloxetine Hcl | 21 | $278 |
| Doxycycline Hyclate | 11 | $202 |
| Mupirocin | 23 | $190 |
| Gabapentin | 25 | $176 |
| Terbinafine Hcl | 27 | $147 |
| Cefadroxil | 15 | $124 |
| Meloxicam | 28 | $90 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Brooklyn
- Yaneth EstradaBrooklyn$2K
- Daniel PollackBrooklyn$2K
- Jaideep ChopraBrooklyn$611
- Samuel WaissBrooklyn$364
- Lyudmila MirochnikBrooklyn$218
- Dawn YamashitaBrooklyn$209
- Anthony IorioNorth Salem$177K
- Brian StraussYonkers$20K
- Martin WendelkenBronx$14K
- Nicholas MegdanisBayside$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.